Virtual reality‐based cognitive‐motor training for middle‐aged adults at high Alzheimer's disease risk: A randomized controlled trial
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Introduction: Ubiquity of Alzheimer's disease (AD) coupled with relatively ineffectual pharmacologic treatments has spurred interest in nonpharmacologic lifestyle interventions for prevention or risk reduction. However, evidence of neuroplasticity notwithstanding, there are few scientifically rigorous, ecologically relevant brain training studies focused on building cognitive reserve in middle age to protect against cognitive decline. This pilot study will examine the ability of virtual reality (VR) cognitive training to improve cognition and cerebral blood flow (CBF) in middle‐aged individuals at high AD risk due to parental history. Methods: The design is an assessor‐blind, parallel group, randomized controlled trial of VR cognitive‐motor training in middle‐aged adults with AD family history. The experimental group will be trained with adaptive “real‐world” VR tasks targeting sustained and selective attention, working memory, covert rule deduction, and planning, while walking on a treadmill. One active control group will perform the VR tasks without treadmill walking; another will walk on a treadmill while watching scientific documentaries (nonspecific cognitive stimulation). A passive (waitlist) control group will not receive training. Training sessions will be 45 minutes, twice/week for 12 weeks. Primary outcomes are global cognition and CBF (from arterial spin labeling [ASL]) at baseline, immediately after training (training gain), and 3 months post‐training (maintenance gain). We aim to recruit 125 participants, including 20 passive controls and 35 in the other groups. Discussion: Current pharmacologic therapies are for symptomatic AD patients, whereas nonpharmacologic training is administrable before symptom onset. Emerging evidence suggests that cognitive training improves cognitive function. However, a more ecologically valid cognitive‐motor VR setting that better mimics complex daily activities may augment transfer of trained skills. VR training has benefited clinical cohorts, but benefit in asymptomatic high‐risk individuals is unknown. If effective, this trial may help define a prophylactic regimen for AD, adaptable for home‐based application in high‐risk individuals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
The global prevalence of dementia: a systematic review and metaanalysis.
Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., & Ferri, C. P. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.11.007 · Cited by 4,941
What is cognitive reserve? Theory and research application of the reserve concept
STERN, Y. (2002) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617702813248 · Cited by 3,951
CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials
Schulz, K. F., Altman, D. G., Moher, D., & for the CONSORT Group* (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-11-201006010-00232 · Cited by 3,824
What is meant by intention to treat analysis? Survey of published randomised controlled trials
Hollis, S., & Campbell, F. (1999) · BMJ · doi:10.1136/bmj.319.7211.670 · Cited by 2,160
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Salloway, S., Sperling, R., Fox, N. C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Ferris, S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1304839 · Cited by 1,960
Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
Doody, R. S., Thomas, R. G., Farlow, M., Iwatsubo, T., Vellas, B., Joffe, S., Kieburtz, K., Raman, R., Sun, X., Aisen, P. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312889 · Cited by 1,668
A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
Doody, R. S., Raman, R., Farlow, M., Iwatsubo, T., Vellas, B., Joffe, S., Kieburtz, K., He, F., Sun, X., Thomas, R. G., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1210951 · Cited by 1,224
Review on cybersickness in applications and visual displays
Rebenitsch, L., & Owen, C. (2016) · Virtual Reality · doi:10.1007/s10055-016-0285-9 · Cited by 971
Rebok, G. W., Ball, K., Guey, L. T., Jones, R. N., Kim, H., King, J. W., Marsiske, M., Morris, J. N., Tennstedt, S. L., Unverzagt, F. W., et al. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12607 · Cited by 965
Cited by
Park, M. J., Kim, D. J., Lee, U., Na, E. J., & Jeon, H. J. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00505 · Cited by 436
Zhang, M., Ding, H., & Zhang, Y. (2022) · doi:10.20944/preprints202202.0056.v1 · Cited by 211
(2022) · doi:10.3390/bs12050138 · Cited by 211
Bevilacqua, R., Maranesi, E., Riccardi, G. R., Di Donna, V., Pelliccioni, P., Luzi, R., Lattanzio, F., & Pelliccioni, G. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111882 · Cited by 125
“Quality evaluation was performed based on the PEDro scale and on the Cochrane’s Risk of Bias (RoB) tool, suggested for evidence based review of rehabilitation while using non-immersive virtual reality [32,33].”
MethodHsieh, C.-H., Chen, C.-M., Yang, J.-Y., Lin, Y.-J., Liao, M.-L., & Chueh, K.-H. (2022) · Landscape and Ecological Engineering · doi:10.1007/s11355-021-00480-9 · Cited by 28
Natural interaction in virtual reality: impact on the cognitive load
Galais, T., Delmas, A., & Alonso, R. (2019) · Adjunct Proceedings of the 31st Conference on l'Interaction Homme-Machine · doi:10.1145/3366551.3370342 · Cited by 22
Metadata
- Authors
- Doniger, G. M., Beeri, M. S., Bahar‐Fuchs, A., Gottlieb, A., Tkachov, A., Kenan, H., Livny, A., Bahat, Y., Sharon, H., Ben‐Gal, O., Cohen, M., Zeilig, G., & Plotnik, M.
- Venue
- Alzheimer's & Dementia: Translational Research & Clinical Interventions
- Publisher
- Wiley
- Published
- 2018-01
- Volume
- 4
- Issue
- 1
- Pages
- 118-129
- ISSN
- 2352-8737 (ISSN-L)
- OpenAlex
- W2794532029
- Cited by
- 112
- References
- 16
- FWCI
- 7.63
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.